Optimal Cost-Effective Screening for Iron Deficiency Anemia
Use serum ferritin as the primary screening test with a threshold of ≤30 ng/mL for general adults (excluding menstruating/pregnant individuals), and consider ≤50 ng/mL for those with symptoms or ongoing risk factors 1.
Screening Strategy by Population
For Non-Menstruating Adults
- Start with serum ferritin alone as your initial screening test 1
- Use ≤30 ng/mL as the diagnostic threshold (pooled sensitivity 0.41, specificity 0.99 at ≤15 ng/mL; higher sensitivity at ≤30 ng/mL) 1
- For symptomatic patients or those with ongoing risk factors (heavy bleeding, malabsorption, chronic disease), raise the threshold to ≤50 ng/mL 1
- This approach is more cost-effective than the older strategy of measuring serum iron and TIBC first 2
For Pregnant Individuals
- Screen at 30 μg/L ferritin threshold - this is definitively the most cost-effective strategy with an incremental cost-effectiveness ratio of $34,000/QALY compared to no screening 3
- Screen during second and third trimesters regularly 3
- The 30 μg/L threshold was favored in 100% of 10,000 Monte Carlo iterations and remained optimal across all sensitivity analyses 3
For Children (Ages 1-4 Years)
- Use serum ferritin ≤20 ng/mL as the threshold 1
- The panel deliberately chose higher sensitivity over specificity in this age group due to the severe consequences of missing iron deficiency during critical developmental periods 1
Why Ferritin Alone is Most Cost-Effective
The evidence strongly supports abandoning the older multi-test approach:
- Ferritin has superior diagnostic performance compared to hemoglobin, hematocrit, serum iron, or TIBC alone 4, 5
- The outdated strategy of measuring serum iron/TIBC first, then adding ferritin selectively, saves only 35-40% of reagent costs but misses cases 2
- Modern guidelines explicitly recommend against using hemoglobin or hematocrit alone for screening 4
Important Caveats
When Ferritin May Be Misleading
- Inflammation elevates ferritin as an acute phase reactant - ferritin can be normal or high despite true iron deficiency 1, 4
- In patients with known/suspected inflammation, a separate diagnostic approach is needed (the guidelines note this requires different thresholds) 1
- Aging also affects ferritin levels 4
When to Add Additional Tests
If ferritin results are equivocal or inconsistent with clinical picture:
- Consider adding reticulocyte hemoglobin content (RET-He) and reticulocyte-derived indices if available on modern analyzers - these show AUC >85% for iron deficiency 6
- A composite index combining RDW-CV, platelet count, and reticulocyte parameters achieved 87% sensitivity and 72.3% specificity 6
- Alternatively, consider a time-limited therapeutic trial of iron when tests are inconclusive 4
Cost-Effectiveness Evidence Strength
The recommendation for ferritin-based screening is supported by:
- Strong guideline consensus from the 2026 American Society of Hematology guidelines 1 and 2025 Lancet Haematology expert consensus 4
- Rigorous cost-effectiveness analysis specifically for pregnancy showing 30 μg/L threshold is optimal 3
- The evidence is rated as low certainty for health outcomes, but this reflects lack of research rather than evidence of ineffectiveness 1
Common Pitfalls to Avoid
- Don't screen with CBC alone - hemoglobin only detects anemia, missing non-anemic iron deficiency which still causes significant morbidity 4, 5
- Don't use the old 15 ng/mL threshold - this misses too many cases (sensitivity only 0.41) 1
- Don't order multiple tests simultaneously in uncomplicated cases - ferritin first is most cost-effective 2
- Don't ignore symptoms - if patient is symptomatic, use the higher 50 ng/mL threshold regardless of population 1
The evidence consistently demonstrates that single-test ferritin screening at appropriate thresholds provides the best balance of diagnostic accuracy and cost-effectiveness across most populations 1, 4, 3.